Listeria monocytogenes: a potent vaccine vector for neoplastic and infectious disease.
about
Alteration of pulmonary immunity to Listeria monocytogenes by diesel exhaust particles (DEPs). II. Effects of DEPs on T-cell-mediated immune responses in ratsRegression of established human papillomavirus type 16 (HPV-16) immortalized tumors in vivo by vaccinia viruses expressing different forms of HPV-16 E7 correlates with enhanced CD8(+) T-cell responses that home to the tumor siteEpitope-Specific Vaccination Limits Clonal Expansion of Heterologous Naive T Cells during Viral ChallengeConditional lethality yields a new vaccine strain of Listeria monocytogenes for the induction of cell-mediated immunityListeria pathogenesis and molecular virulence determinantsListeria monocytogenes as a short-lived delivery system for the induction of type 1 cell-mediated immunity against the p36/LACK antigen of Leishmania major.Brucella abortus strain RB51 as a vector for heterologous protein expression and induction of specific Th1 type immune responses.CD8(+)-T-cell response to secreted and nonsecreted antigens delivered by recombinant Listeria monocytogenes during secondary infection.Intracellular bacteria as targets and carriers for vaccination.Dendritic cells: immune saviors or Achilles' heel?The efficacy of genetic vaccination is dependent upon the nature of the vector system and antigen.Acid shock of Listeria monocytogenes at low environmental temperatures induces prfA, epithelial cell invasion, and lethality towards Caenorhabditis elegans.Engineered commensal bacteria as delivery systems of anti-infective mucosal protectants.Intranasal vaccination with the recombinant Listeria monocytogenes ΔactA prfA* mutant elicits robust systemic and pulmonary cellular responses and secretory mucosal IgA.Live bacteria as the basis for immunotherapies against cancer.Listeria and Salmonella bacterial vectors of tumor-associated antigens for cancer immunotherapy.Oral immunization with recombinant listeria monocytogenes controls virus load after vaginal challenge with feline immunodeficiency virusLm-LLO-Based Immunotherapies and HPV-Associated DiseaseProgress towards the use of Listeria monocytogenes as a live bacterial vaccine vector for the delivery of HIV antigens.Immunotherapy for gynaecological malignancies.Listeria monocytogenes as a vector for tumor-associated antigens for cancer immunotherapy.Selected prfA* mutations in recombinant attenuated Listeria monocytogenes strains augment expression of foreign immunogens and enhance vaccine-elicited humoral and cellular immune responses.Smart adjuvants.Induction of protective cellular immunity against Mycobacterium tuberculosis by recombinant attenuated self-destructing Listeria monocytogenes strains harboring eukaryotic expression plasmids for antigen 85 complex and MPB/MPT51Liposome-encapsulated antigens induce a protective CTL response against Listeria monocytogenes independent of CD4+ T cell help.
P2860
Q23923284-AC0D4F07-3C59-47E0-B4EB-5E894C259DF8Q33846428-3074F25B-E39F-488B-916A-1AF7FADDA72BQ33889670-4201A90A-7C21-4E12-84EC-8C82C99C71DDQ33946547-9B137D6B-3D85-4099-959A-F34476553557Q33975740-B31D557F-B65C-4EDB-8DA6-81BB68A757F7Q34003632-F4BDF100-5B26-44F5-A58D-E040ADE80572Q34004646-54096DB2-548B-411B-9D29-7FA77E8522DFQ34115899-2B0889FC-96D2-4B04-B6A5-D9A44C598C54Q34280918-05075072-9CE6-4B80-93E6-65AC145D21CBQ34304644-DE9B4A06-AE0A-4D4F-872C-20ADC6988819Q34482074-158C1EDC-519B-43D9-B6FA-D1B4992FD2DCQ34690940-6CA7F798-266A-4060-9AEB-504AB2BE9120Q35042482-D8B76A11-E2F6-4E51-87BA-0286DB30B5A2Q35066276-BEE7A213-7EAF-4711-9AF2-E713D9D2ED61Q35193514-7E2BC29F-91C7-40DB-9ACE-790164312C75Q35543083-EE3B26A0-AC89-4475-9F2B-38D980E9DA8EQ35705707-5738640A-3E5B-4348-9CC9-2F32AFA56765Q35838127-6D46F399-575C-4C7B-9EC5-AAA76A348074Q35851806-9991D0AA-65C5-4E34-89E1-CF7F8C5FC0F6Q36239661-2D608D61-BA8B-4349-999E-401177FF9F4DQ36600365-185DF796-AF5D-4B50-BA57-480BC59267F8Q36804270-60918729-E7E9-4CAA-BF05-1FB88D6CEC60Q36837149-D96539D4-11FA-4434-90AE-77E10EDCAAFDQ37117196-04F5B5E6-FC87-476F-9554-B572D01AB139Q39988900-147DF20D-F3DF-451F-9424-9A711A825FA4
P2860
Listeria monocytogenes: a potent vaccine vector for neoplastic and infectious disease.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Listeria monocytogenes: a potent vaccine vector for neoplastic and infectious disease.
@en
type
label
Listeria monocytogenes: a potent vaccine vector for neoplastic and infectious disease.
@en
prefLabel
Listeria monocytogenes: a potent vaccine vector for neoplastic and infectious disease.
@en
P2860
P1476
Listeria monocytogenes: a potent vaccine vector for neoplastic and infectious disease.
@en
P2093
Paterson Y
Weiskirch LM
P2860
P304
P356
10.1111/J.1600-065X.1997.TB01002.X
P577
1997-08-01T00:00:00Z